arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

10x Genomics, Inc.

TXG

$52.15 ▲ +6.55 (+14.35%) at close

10 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

10x Genomics, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.5B

Dividend Yield —

Revenue Growth 5.2% ↗

Op. Margin -9.5% ↗

ROIC -8.4% ↗

FCF / Share $1.04 ↗

Trailing P/E —

Price / Book 8.4x

FCF Yield 2.0%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$642.82M

↑ +5.2% —

Net Income Profit after all expenses

$-43.54M

↑ +76.2% —

Operating Margin Operating profit as % of sales

-9.5%

↑ +70.2% 16th

FCF / Share Free cash flow per share

$1.04

↑ +2292.9% —

Long-Term Debt Long-term obligations

$29.72M

↑ +16.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	5.2% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: At sector avg	-1.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-126%)	19.8% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+296%)	5.3% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6%)	64.1% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1183%)	21.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+331%)	68.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1261%)	105.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2017%)	—	—
EPS Growth YoY (%)	77.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	30.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-49.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-175.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	90.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	76.2% Excellent ↑ Excellent Improving Year-over-year change in net income	28.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-53.7% Weak ↑ Weak Improving Year-over-year change in net income	-185.1% Weak ↑ Weak Improving Year-over-year change in net income	89.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-1636.7% Weak ↓ Weak Declining Year-over-year change in net income	72.2% Excellent Excellent Year-over-year change in net income	-499.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	91.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	62.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-30.6% Weak Weak Year-over-year change in free cash flow	55.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	7.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	7.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	27.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	28.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	49.7% Excellent Excellent Compound annual revenue growth over 3 years	61.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	16.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	20.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	33.4% Excellent Excellent Compound annual revenue growth over 5 years	48.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	-9.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-179%)	-31.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-365%)	-42.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-457%)	-32.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-371%)	-10.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-189%)	-178.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1589%)	-12.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-204%)	-75.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-731%)	-25.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-315%)	—
Effective Tax Rate (%) (%)	-9.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-8.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-6.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-185%)	-29.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-474%)	-41.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-615%)	-32.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-502%)	-11.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-248%)	-181.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2370%)	-12.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-259%)	-76.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1061%)	-26.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-430%)	—
FCF Margin (%) (%)	20.2% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-10.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-32.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-25.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-85.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-3.3% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-56.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-20.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	-2.99x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	2.11x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-8.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-73.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	57.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	16.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-5.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-89.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-5.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-25.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-271%)	-34.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-329%)	-20.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-7.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-73.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-590%)	-7.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	51.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+241%)	16.7% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+11%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	-0.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-117%)	—	—
Interest Coverage (x)	—	—	-8040.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-352.82x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-60.34x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-317.56x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.93x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-45.98x Weak Weak Operating income divided by interest expense Optimal: > 5x	-22.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	$-344.07M	$-359.28M	$-219.75M	$-587.45M	$-663.60M	$-394.45M	$-39.59M	$-47.86M	—
Debt / EBITDA (x)	—	—	—	—	—	—	-1.26x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.24x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$5.15	$5.07	$5.28	$4.54	$4.44	$2.95	—	—	—	—
Basic EPS, GAAP (USD)	$-0.35	$-1.52	$-2.18	$-1.46	$-0.53	$-5.37	—	—	—	—
Free Cash Flow per Share (USD)	$1.04	$-0.05	$-0.54	$-1.45	$-1.11	$-2.52	—	—	—	—
Book Value per Share (USD)	$6.24	$5.81	$6.22	$6.99	$7.27	$6.81	$4.36	$-15.12	—	—
Tangible Book Value per Share (USD)	$5.71	$5.64	$6.04	$6.76	$7.00	$6.61	$4.36	$-15.12	—	—
Basic Weighted Avg Shares (shares)	124.75M	120.45M	117.17M	113.86M	110.35M	101.15M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$531.00M	$466.75M	$468.86M	$504.08M	$637.23M	$656.24M	$417.79M	$73.87M	—	—
LT Debt (USD)	—	—	—	—	—	—	$29.72M	$25.49M	—	—
Total Equity (USD)	$796.33M	$710.13M	$741.04M	$805.74M	$817.57M	$739.07M	$420.08M	$-219.99M	$-112.51M	$-96.43M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$642.82M	$610.78M	$618.73M	$516.41M	$490.49M	$298.85M	$245.89M	$146.31M	$71.08M	—
Depreciation Expense (USD)	$36.20M	$35.88M	$35.51M	$25.37M	$21.12M	$14.01M	$7.07M	$3.90M	$4.30M	—
Net Income, GAAP (USD)	$-43.54M	$-182.63M	$-255.10M	$-166.00M	$-58.22M	$-542.73M	$-31.25M	$-112.48M	$-18.76M	—
Operating Cash Flow (USD)	$136.05M	$6.66M	$-15.20M	$-33.61M	$-21.37M	$-217.90M	$34.63M	$-76.41M	$-10.70M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters

10x Genomics, Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TXG with peers